100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
First Line Treatment (NAPLEX REVIEW) Exam Questions and Answers 2024/2025( A+ GRADED 100% VERIFIED). R208,05   Add to cart

Exam (elaborations)

First Line Treatment (NAPLEX REVIEW) Exam Questions and Answers 2024/2025( A+ GRADED 100% VERIFIED).

 2 views  0 purchase
  • Course
  • First Line Treatment
  • Institution
  • First Line Treatment

First Line Treatment (NAPLEX REVIEW) Exam Questions and Answers 2024/2025( A+ GRADED 100% VERIFIED).

Preview 3 out of 16  pages

  • September 21, 2024
  • 16
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • First Line Treatment
  • First Line Treatment
avatar-seller
First Line Treatment (NAPLEX REVIEW)
Diabetes - ANS T1D: insulin
T2D: metformin
ASCVD or CKD risk: SGLT2 (-) or GLP-1 agonist
HF risk: SGLT2 (-)
wt loss: SGLT2 (-), GLP-1 agonist
cost: SU, TZDs
hypoglycemia risk: avoid insulin and SU together

DKA and HHS - ANS 1. fluids: NaCl first, then switch to D5W1/2NS when BG < 200
2. regular insulin (0.1u/kg)
3. prevent hypokalemia (monitor potassium)
4. treat acidosis (pH < 6.5) with sodium bicarb

Hypothyroidism - ANS 1st line: levothyroxine (1.6mcg/kg--using IBW)
alternatives: liothyronine, armour thyroid
if low salt intake: consume food with iodine (dairy, seafood, meat, bread) or take multivitamin
with iodine

Hyperthyroidism - ANS 1st line: meds (PTU--preferred in in 1st trimester if pregnant,
methimazole--preferred in 2nd and 3rd trimester if pregnant), radioactive iodine (destroy parts of
the gland--take with potassium iodine to prevent cancer) or surgery
beta-blockers for symptom control

Thyroid Storm (decompensated hyperthyroidism) - ANS 1st line: PTU
alternatives: inorganic iodine therapy (SSKI drops), beta blockers (propranolol), steroids
(dexamethasone), APAP or other supportive therapy to help cool down temp

Rheumatoid arthritis (RA) - ANS non drug: PT, rest, exercise, diet/weight control, surgery (joint
replacement)
drug: 1. DMARDs--traditional/non-biologic or biologics (TNF inhibitor or non-TNF inhibitor), 2.
steroids (used to bridge till DMARD takes effect), 3. NSAIDs
options: MTX (1st line) +/- steroid or 2 DMARDS (biologic + non-biologic or 2 non biologic)

Lupus - ANS non drug: rest, exercise, sun protection, quit smoking
drug:
mild-NSAIDS + PPI (reduce GI risk)
mod-sev (1 or more immunosuppressants): steroids, hydroxychloroquine, cyclophosphamide,
azathioprine, mycophenolate, cyclosporine, anifrolumab (saphnelo), belimumab (benlysta)

,multiple sclerosis - ANS 1.steroids--exacerbations (IV methylprednisolone 3-7 days)
2. disease modifying therapies (1st line)
3. supportive therapy: (anticholinergics--incontinence, laxatives--constipation,
loperamide--diarrhea, skeletal muscle relaxants or analgesics--muscle spasms and pain,
propranolol--tremors, SNRI--neuropathic pain, modafinil--fatigue, stimulants--ADHD,
scopolamine or meclizine--dizziness, donepezil--cognitive function, PDE-5 (-)---ED)

Raynauds - ANS calcium channel blocker (nifedipine)
alternatives: iloprost, topical NTG, PDE-5 (-)

celiac disease - ANS avoid gluten (avoid starch products--corn, potato, tapioca, wheat, etc.)

myasthenia gravis - ANS 1st line: cholinesterase inhibitors (pyridostigmine)--stop ACh
breakdown to reduce muscle weakness
alternatives/add ons: steroids, azathioprine, IVIG (severe), efgartigimod (vyvgart)

sjogren's syndrome - ANS dry eyes: artificial tears (OTC: systane, refresh, RX: restasis,
lifitegrast (xiidra))
dry mouth: (OTC: sugar free chewing gum/lozenge, antimicrobial mouthwash, salivary
substitutes, RX: oral muscarinic agonists--pilocarpine, cevimeline)

psoriasis - ANS non drug: oatmeal bath, UV light exposure--reduces scaling and inflammation,
photochemotherapy/laser light therapy
drug (1st line): topical meds (steroids, vitamin D analog (calcipotriene), anthralin, retinoids,
salicylic acid, coal tar, moisturizers
2nd line: topical calcineurin (-): protopic, elidel
severe: MTX, cyclosporine, hydroxyurea, entarecept, humira, infliximab, etc.)

pulmonary arterial hypertension - ANS -treat underlying causes (toxin, drug or disease
associated)
-CTEPH (chronic thromboembolism pulmonary HTN): warfarin
-non drug: sodium restriction, avoid NSAIDs, vaccinations (flu, pneumonia), avoid high altitudes
(causes hypoxia--trigger), oxygen
-drug (responders): calcium channel blockers (nifedipine, diltiazem, amlodipine)
-drug (non-responders/responders that failed CCB therapy)

pulmonary fibrosis - ANS chronic oxygen supplementation, pirfenidone (esbriet), nintedanib
(ofev)---both drugs slow rate of lung function decline

Asthma - ANS ICS or ICS/LABA (formoterol)

COPD - ANS Bronchodilators
Class A: SABA or SAMA PRN, LABA or LAMA
Class B: LAMA or LABA

, Class C: LAMA
Class D: LAMA, LAMA/LABA, or ICS/LABA (eos > 300)
Exacerbation: SABA + oral steroid

Tobacco cessation - ANS non drug: counseling
drug: NRT (patch, gum, lozenge, inhaler, spray), bupropion, varenicline

Hyperlipidemia - ANS Statins
add on: ezetimibe or pcsk9 (-)

Hypertension - ANS ACE/ARB, thiazides, DHP calcium channel blockers
others: beta blockers, clonidine, guanfacine, hydralazine, methyldopa, alpha blockers

stable ischemic heart disease (chest pain/angina) - ANS antiplatelets: aspirin, clopidogrel, both
(stent only)
antianginals: nitrates, beta blockers, CCBs

acute coronary syndromes - ANS PCI (revascularization procedure--preferred for STEMI)
if not possible with 120 min, give fibrinolytic within 30 min of hospital arrival
1st line drugs: morphine sulfate, oxygen, nitrate, aspirin (MONA)
next: anticoags, clopidogrel, beta blockers, ACE inhibitors

Heart Failure - ANS 1st: ACE/ARB/ARNI + beta blocker + loop diuretic
add on: spironolactone, then SGLT2, hydralazine, ivandrabine
last line: digoxin, vericiguat

Arrhythmias - ANS Rate: Class 2 or 4 (beta blockers and non-DHP CCBs)
Rhythm: cardioversion-Class 1 or 3 (Na and K blockers) + anticoagulant for stroke prophylaxis
(3 weeks before, 4 weeks after)

Ischemic Stroke (acute) - ANS remove clot w/ stent or dissolve clot with IV fibrinolytics
(alteplase), aspirin and/or clopidogrel or ticagrelor within 24-48 hrs and continued for 21-90 days
administer alteplase:
-30 min of STEMI
-3 hours of symptom onset
-60 min of hospital arrival

Ischemic Stroke (chronic prophylaxis) - ANS noncardioembolic: antiplatelet monotherapy
(aspirin or clopidogrel)
cardioembolic: oral anticoagulant (DOACS or warfarin)

hemorrhagic stroke - ANS if on anticoagulant: use reversal agent
treat seizures
lower ICP: mannitol or hypertonic sol'n

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying this summary from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller KINGJAY. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy this summary for R208,05. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

81849 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy summaries for 14 years now

Start selling
R208,05
  • (0)
  Buy now